NCT03112330View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Atrophic Rhinitis

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 8, 2017

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2019

Conditions
Atrophic Rhinitis
Interventions
DEVICE

Plasma rich platelet injection

Plasma rich platelet injection with 26-gauge needle and 2cc syringe on inferior turbinate mucosa

DEVICE

Saline nasal spray

two puffs of isotonic saline nasal spray twice daily

Trial Locations (1)

06591

Seoul St. Mary's Hospital, Seoul

All Listed Sponsors
lead

Seoul St. Mary's Hospital

OTHER

NCT03112330 - A Clinical Study to Evaluate the Safety and Efficacy of Platelet Rich Plasma Injection for Atrophic Rhinitis | Biotech Hunter | Biotech Hunter